Indivior Pharmaceuticals (INDV) Long-Term Investments (2022 - 2026)

Indivior Pharmaceuticals' Long-Term Investments history runs 5 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• In Q1 2026, Long-Term Investments changed 0.0% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $27.0 million (changed 0.0% YoY), while the FY2025 annual figure was $28.0 million, up 3.7% from the prior year.
• Long-Term Investments was $27.0 million for Q1 2026 at Indivior Pharmaceuticals, down from $28.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $98.0 million in Q4 2022 to a low of $27.0 million in Q4 2024.
• Historically, Long-Term Investments has averaged $37.9 million across 5 years, with a median of $27.5 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Long-Term Investments plunged 58.16% in 2023, then increased 3.7% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $98.0 million in 2022, then slumped by 58.16% to $41.0 million in 2023, then sank by 34.15% to $27.0 million in 2024, then climbed by 3.7% to $28.0 million in 2025, then declined by 3.57% to $27.0 million in 2026.
• The last three Long-Term Investments figures came in at $27.0 million (Q1 2026), $28.0 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.